New York State Common Retirement Fund
OVID icon

New York State Common Retirement Fund’s Ovid Therapeutics OVID Stock Holding History

New York State Common Retirement Fund’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,986
Closed -$5.92K – 3302
2025
Q1 		$5.92K Hold
18,986
– – ﹤0.01% 3115
2024
Q4 		$17.7K Hold
18,986
– – ﹤0.01% 3061
2024
Q3 		$22.4K Hold
18,986
– – ﹤0.01% 3028
2024
Q2 		$14.6K Buy
18,986
+311
+2% +$865 ﹤0.01% 3227
2024
Q1 		$57K Sell
18,675
-307
-2% -$1.03K ﹤0.01% 2947
2023
Q4 		$61.1K Sell
18,982
-128
-0.7% -$438 ﹤0.01% 2939
2023
Q3 		$73.4K Sell
19,110
-7,690
-29% -$27.6K ﹤0.01% 2879
2023
Q2 		$87.9K Buy
+26,800
New +$91K ﹤0.01% 2957
2021
Q3 		– Sell
-378
Closed -$1K – 3472
2021
Q2 		$1K Sell
378
-38,622
-99% -$152K ﹤0.01% 3444
2021
Q1 		$157K Hold
39,000
– – ﹤0.01% 2920
2020
Q4 		$90K Sell
39,000
-200
-0.5% -$932 ﹤0.01% 3063
2020
Q3 		$225K Hold
39,200
– – ﹤0.01% 2595
2020
Q2 		$289K Buy
+39,200
New +$183K ﹤0.01% 2485
2019
Q2 		– Sell
-7,900
Closed -$14K – 3285
2019
Q1 		$14K Hold
7,900
– – ﹤0.01% 3140
2018
Q4 		$19K Hold
7,900
– – ﹤0.01% 3159
2018
Q3 		$45K Hold
7,900
– – ﹤0.01% 3111
2018
Q2 		$62K Hold
7,900
– – ﹤0.01% 3132
2018
Q1 		$56K Hold
7,900
– – ﹤0.01% 3022
2017
Q4 		$78K Hold
7,900
– – ﹤0.01% 3010
2017
Q3 		$68K Hold
7,900
– – ﹤0.01% 3042
2017
Q2 		$83K Buy
+7,900
New +$103K ﹤0.01% 3111

Other funds holding OVID

TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

New York State Common Retirement Fund's OVID Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of Ovid Therapeutics (OVID) in Q2 2025, closing a stake of 18,986 shares — an estimated $5.92K sold.

New York State Common Retirement Fund first reported a position in OVID in Q2 2017 and held it in 21 quarters. The position peaked at $289K in Q2 2020. 71 funds tracked by Wall St. Rank hold OVID as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining Ovid Therapeutics position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 18,986 Ovid Therapeutics shares in Q2 2025, an estimated $5.92K.
  • New York State Common Retirement Fund first reported a position in Ovid Therapeutics in Q2 2017 and held it in 21 quarters.
  • New York State Common Retirement Fund's Ovid Therapeutics position peaked at $289K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.